medigraphic.com
Anales de Otorrinolaringología Mexicana

2024, Number 4

<< Back Next >>

Otorrinolaringología 2024; 69 (4)

Neonatal hearing screening in Mexico: Experience of a second level care center

Gastelum GW, Mariscal MB, Celis AEM, Hernández CEN, de la Mora FAR

Language: Spanish
References: 39
Page: 251-264
PDF size: 348.33 Kb.


ABSTRACT

Background: Congenital hearing loss constitutes the initial step in the Neonatal Hearing Screening and Early Intervention program (TANIT) in Mexico, it is considered a diagnostic challenge within the first months of life, where hearing plays a key role in future human development.
Objective: To know the degree of compliance with the goals for hearing screening of the TANIT, as well as the prevalence of risk factors in patients with absent otoacoustic emissions in Mexico.
Methodology: Comprehensive review of primary literature on PubMed and Google Scholar as database platforms. The keywords used were: hearing loss, congenital hearing loss in Mexico, otoacoustic emissions, neonatal auditory screening, emitted evoked potentials, hearing loss screening in Mexico, from 1990 to 2023. The Mexican literature and population were reviewed with greater insistence. The most representative sources were included in the international category for global analysis.
Results: There were obtained 3960 evaluable results. Nowadays developing countries have a higher incidence of patients with deafness. Six thousand children with hearing loss are born in Mexico; however, more than 80% of patients are diagnosed after one year of age, so it is essential to achieve a timely neonatal screening by otoacoustic emissions.
Conclusions: Achieving timely treatment of congenital hearing loss requires early diagnosis and achieving satisfactory coverage of hearing screening is still a great challenge for developing countries like Mexico.


REFERENCES

  1. Organización Panamericana de la Salud. Tamizaje auditivo: consideraciones para su implementación. 2021.

  2. Secretaría de Salud. Programa de acción específico 2007-2012. Tamiz auditivo neonatal e intervencióntemprana. 2009; 1-52.

  3. Burke MJ, Shenton RC, Taylor MJ. The economics of screening infants at risk of hearing impairment: Aninternational analysis. Int J Pediatr Otorhinolaryngol 2012; 76 (2): 212-8. doi: 10.1016/j.ijporl.2011.11.004

  4. Jakubíková J, Kabátová Z, Pavlovcinová G, Profant M. Newborn hearing screening and strategy for earlydetection of hearing loss in infants. Int J Pediatr Otorhinolaryngol 2009; 73 (4): 607-12. doi: 10.1016/j.ijporl.2008.12.006

  5. Korver AM, Smith RJ, Van Camp G, Schleiss MR, et al. Congenital hearing loss. Nat Rev Dis Primers 2017;3: 1-17. doi: 10.1038/nrdp.2016.94

  6. Haydeé R, Aguilar R, En E, Pablo P, et al. Universidad Autónoma del Estado de México. Facultad de Medicina.Coordinación de Investigación y Estudios Avanzados. Departamento de Estudios Avanzados. Coordinación dela Especialidad en Pediatría. Departamento de Evaluación Profesional. “Incidencia de la sordera-hipoacusiacongénita a través del tamiz”. http://ri.uaemex.mx/bitstream/handle/20.500.11799/14415/408847.pdf

  7. Reyes-Gelves CA, Mejía-Perdigón LJ, Carvajalino-Monje I, Morón LS, Gelves-Rosales JA. Factores de riesgopara el desarrollo de hipoacusia neurosensorial congénita: análisis de 10 años. Acta Otorrinolaringol CirCabeza Cuello 2018; 42 (2): 87-92.

  8. van Dommelen P, Mohangoo AD, Verkerk PH, van der Ploeg CP, van Straaten HL. Risk indicators for hearingloss in infants treated in different neonatal intensive care units. Acta Paediatr 2010; 99 (3): 344-9. doi:10.1111/j.1651-2227.2009.01614.x

  9. Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateralhearing loss: a quantitative assessment. J Clin Virol 2008; 41 (2): 57-62. doi: 10.1016/j.jcv.2007.09.004

  10. Koffler T, Ushakov K, Avraham KB. Genetics of hearing loss: Syndromic. Otolaryngol Clin North Am 2015;48 (6): 1041-61. doi: 10.1016/j.otc.2015.07.007

  11. Parker M, Bitner-Glindzicz M. Genetic investigations in childhood deafness. Arch Dis Child 2015; 100 (3):271-8. doi: 10.1136/archdischild-2014-306099

  12. Mahboubi H, Dwabe S, Fradkin M, Kimonis V, Djalilian HR. Genetics of hearing loss: where are we standingnow? Eur Arch Otorhinolaryngol 2012; 269 (7): 1733-45. doi: 10.1007/s00405-011-1910-6

  13. Gracey K. Current concepts in universal newborn hearing screening and early hearing detection and interventionprograms. Adv Neonatal Care 2003; 3(6): 308-17. doi: 10.1016/j.adnc.2003.09.007

  14. Rubio-Partida GA, Celis-Aguilar E, Verdiales-Lugo S, Castro-Urquizo A, et al. Neuropatía auditiva en México:la importancia de realizar potenciales auditivos de tallo. An Orl Mex 2020;65(3):137-46.

  15. American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: Principlesand guidelines for early hearing detection and intervention programs. Pediatrics 2007; 120 (4): 898-921.https://doi.org/10.1542/peds.2007-2333

  16. Nelson HD, Bougatsos C, Nygren P; 2001 US Preventive Services Task Force. Universal newborn hearingscreening: systematic review to update the 2001 US Preventive Services Task Force Recommendation. Pediatrics2008; 122 (1): e266-76. doi: 10.1542/peds.2007-1422

  17. Ptok M. Frühdiagnostik kindlicher Hörstörungen [Early diagnosis of hearing impairment in children]. ZArztl Fortbild Qualitatssich 2004; 98 (4): 265-70.

  18. Pérez-Abalo MC, Gaya JA, Savio G, Ponce de León M, et al. Diagnóstico e intervención temprana de los trastornosde la audición: una experiencia cubana de 20 años [Early detection and intervention of hearing impairmentin Cuba: outcome after 20 years]. Rev Neurol 2005; 41 (9): 556-63. https://doi.org/10.33588/rn.4109.2004589

  19. Mehl AL, Thomson V. The Colorado newborn hearing screening project, 1992-1999: on the threshold of effectivepopulation-based universal newborn hearing screening. Pediatrics 2002; 109 (1): E7. doi: 10.1542/peds.109.1.e7

  20. Escobar-Ipuz FA, Soria-Bretones C, García-Jiménez MA, Cueto EM, et al. Early detection of neonatal hearingloss by otoacoustic emissions and auditory brainstem response over 10 years of experience. Int J PediatrOtorhinolaryngol 2019; 127: 109647. doi: 10.1016/j.ijporl.2019.109647

  21. González de Aledo Linos A, Bonilla Miera C, Morales Angulo C, Gómez da Casa F, Barrasa Benito J. Cribadouniversal de la hipoacusia congénita en Cantabria: resultados de los dos primeros años. Anales Pediatría2005; 62 (2): 135-40.

  22. Meyer ME, Swanepoel de W, le Roux T, van der Linde M. Early detection of infant hearing loss in the privatehealth care sector of South Africa. Int J Pediatr Otorhinolaryngol. 2012; 76 (5): 698-703. doi: 10.1016/j.ijporl.2012.02.023

  23. NORMA Oficial Mexicana NOM-034-SSA2-2013, Para la prevención y control de los defectos al nacimiento.Secretaría de Salud, Diario Oficial de la Federación; 2014.

  24. De Uzcategiu CA, Yoshinaga-Itano C. Parents’ reactions to newborn hearing screening. Audiol Today 1997; 24: 27.

  25. Söylemez E, Karaboya E, Ertuğrul S, Yılmaz N, et al. Anxiety status in parents of infants referred duringnational newborn hearing screening. Med Records 2023; 5 (1): 79-83. DOI: 10.37990/medr.1163216

  26. Castorena-Maldonado A, RamírezGarcía A, Carranco-Hernández L, Pérez-Delgadillo G, Toledo-Varela M.Análisis geoespacial de la discapacidad auditiva en México. An Orl Mex 2022; 67 (1): 52-61. https://doi.org/10.24245/aorl.v67i1.7377

  27. Liu Q, Chen P, Wang J. Molecular mechanisms and potentials for differentiating inner ear stem cells intosensory hair cells. Dev Biol 2014; 390 (2): 93-101. doi: 10.1016/j.ydbio.2014.03.010

  28. Sanyelbhaa H, Kabel A, Abo El-Naga HAE, Sanyelbhaa A, Salem H. The risk ratio for development of hereditarysensorineural hearing loss in consanguineous marriage offspring. Int J Pediatr Otorhinolaryngol2017; 101: 7-10. doi: 10.1016/j.ijporl.2017.07.020

  29. Zakzouk S. Consanguinity and hearing impairment in developing countries: a custom to be discouraged. JLaryngol Otol 2002; 116 (10): 811-6. doi: 10.1258/00222150260293628

  30. Smith RJ, Bale JF Jr, White KR. Sensorineural hearing loss in children. Lancet 2005; 365 (9462): 879-90.doi: 10.1016/S0140-6736(05)71047-3

  31. Cohen BE, Durstenfeld A, Roehm PC. Viral causes of hearing loss: a review for hearing health professionals.Trends Hear 2014; 18: 2331216514541361. doi: 10.1177/2331216514541361

  32. Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG et al; National Instituteof Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomaticcongenital cytomegalovirus disease. N Engl J Med 2015; 372 (10): 933-43. doi: 10.1056/NEJMoa1404599

  33. De Leenheer EM, Janssens S, Padalko E, Loose D, et al. Etiological diagnosis in the hearing impaired newborn:proposal of a flow chart. Int J Pediatr Otorhinolaryngol 2011; 75 (1): 27-32. doi: 10.1016/j.ijporl.2010.05.040

  34. Vela-Amieva M, Belmont-Martínez L, Ibarra-González I, Fernández-Lainez C. Variabilidad interinstitucionaldel tamiz neonatal en México. Bol Med Hosp Infant Mex 2009; 66 (5): 431-439.

  35. Ornelas López R de J. Experiencia del programa tamiz auditivo neonatal e intervención temprana en elhospital regional de alta especialidad de Veracruz a año y medio de su implementación. 2012. cdigital.uv.mx

  36. Wroblewska-Seniuk K, Greczka G, Dabrowski P, Szyfter-Harris J, Mazela J. Hearing impairment in prematurenewborns—Analysis based on the national hearing screening database in Poland. Parikh NA, editor.PLoS One 2017; 12 (9): e0184359. doi: 10.1371/journal.pone.0184359

  37. Hernández-Herrera RJ, Hernández-Aguirre LM, Castillo-Martínez NE, et al. Tamizaje y confirmacióndiagnóstica de hipoacusia. Neonatos de alto riesgo versus población abierta. Rev Med Inst Mex Seguro Soc2007; 45 (5): 421-426.

  38. Gómez PV, Martínez CA, Ochoa BAM, et al. Prevalencia de hipoacusia y factores de riesgo asociados enrecién nacidos del estado de Colima, México. Otorrinolaringología 2013; 58 (2): 61-66.

  39. González-Amaro C, Reyna-Barrientos M, Hernández-Sierra F, et al. Validez de las emisiones otoacústicaspara detectar hipoacusia en neonatos de alto riesgo. Pediatr Mex 2013; 15 (3): 80-83.




2020     |     www.medigraphic.com